No Data
No Data
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") has executed a non-binding letter of intent (LOI) to extend acquisition debt of US$3,294,440 to
Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee and Reactive Step Trainer 2024 Product Roll-Out
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company") (TSXV: EVMT) announced it has reduced acquisition bank debt by $535,093 as a result of the sale of A
Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the "Company") (TSXV:SGMD), is pleased to announce its corporate name change to Evome Medical Technologies
Salona Global Announces Exclusive Partnership With Recently Launched U.S. Military Veteran (VA)...
Salona Global Announces Debut of the Biodex Reactive Step Trainer
Salona Global Medical Device Corporation (SGMD.V), announced Monday the debut of the Biodex Reactive Step Trainer (RST) -- a medical device that combines Biodex Rehab's gait trainer platform with a c
Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component
NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the "Company") (TSXV:SGMD), announced today the debut of the Biodex Reactive Step Trainer ("RST"): A revoluti